A recent Politico article noted that Pfizer and its partner BioNTech are seeking full approval from the FDA for their Covid-19 vaccine for people 16 and older. The two-dose protection against coronavirus received emergency use authorization earlier this year, which allowed it to be one of three vaccines used in the pandemic battle. Full approval means the companies would be able to market the shot directly to consumers, and make it easier for schools, employers, and the military to require vaccination against Covid-19.
Pfizer Eyes Full FDA Approval for Covid-19 Vaccine
Pfizer and partner BioNTech are the first vaccine manufacturers to seek full approval in the U.S.
May 10, 2021
Recommended
Recommended
Recommended
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
